acebutolol has been researched along with Amentia in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zagórska, A | 1 |
| Bucki, A | 1 |
| Partyka, A | 1 |
| Jastrzębska-Więsek, M | 1 |
| Siwek, A | 1 |
| Głuch-Lutwin, M | 1 |
| Mordyl, B | 1 |
| Jaromin, A | 1 |
| Walczak, M | 1 |
| Wesołowska, A | 1 |
| Kołaczkowski, M | 1 |
1 other study available for acebutolol and Amentia
| Article | Year |
|---|---|
Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia.
Topics: Animals; Antipsychotic Agents; Dementia; Humans; Ligands; Mice; Phosphoric Diester Hydrolases; Serot | 2022 |